A new pilot study published in the journal Obesity Pillars confirms that Sea-Band’s drug-free acupressure wristbands can significantly ease the nausea many people experience when taking GLP-1 medications like Ozempic and Mounjaro. Over four weeks, 31 adults recorded 359 nausea episodes while on their prescribed GLP-1 therapy—Sea-Bands were used every time, and one-third of those bouts cleared up within five minutes of wearing the bands. The remaining episodes resolved within 20 minutes.
GLP-1 receptor agonists have transformed diabetes care and weight-loss treatment, delivering up to 15–22 percent body-weight reduction and cardiovascular benefits. But nausea is common, and nearly a third of patients stop therapy within a month because of it. Sea-Band XL and Standard models work by pressing on the P6 acupressure point inside the wrist—an approach already proven for motion sickness, morning sickness and post-operative nausea. This study, led by obesity medicine specialist Dr. Florencia Ziemke, showed Sea-Bands relieved GLP-1–related nausea in over 80 percent of recorded episodes.
“Prescription anti-nausea drugs can interact with other medications and carry their own side effects,” explains Dr. Ziemke. “Diet changes alone often aren’t enough. These initial results offer hope that a simple wristband can keep patients on life-changing therapies.” While larger trials are needed, the findings suggest Sea-Bands could become an easy, drug-free add-on to help millions tolerate GLP-1 treatments and reach their health goals.